Aspreva Pharmaceuticals Corp. ¡æ Vifor Pharma Ltd.¡ç Galenica Ltd.
|
|
|
|
|
two phase III clinical development programs underway to evaluate CellCept; an orally delivered immunosuppressant agent; in the treatment of the autoimmune diseases; such as lupus nephritis and pemphigus vulgaris | |
Korean Distributor : ??? |
Products information :
|
|
|
|
|
|
|
|
|
|